IBM Retirement Fund reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 84.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,357 shares of the healthcare conglomerate’s stock after selling 75,047 shares during the quarter. IBM Retirement Fund’s holdings in UnitedHealth Group were worth $2,768,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Sandy Spring Bank grew its holdings in shares of UnitedHealth Group by 9.7% in the first quarter. Sandy Spring Bank now owns 12,787 shares of the healthcare conglomerate’s stock valued at $2,097,000 after acquiring an additional 1,134 shares in the last quarter. Capital Wealth Planning LLC bought a new position in UnitedHealth Group during the first quarter valued at $3,245,000. Cipher Capital LP grew its holdings in UnitedHealth Group by 25.4% during the first quarter. Cipher Capital LP now owns 20,446 shares of the healthcare conglomerate’s stock valued at $3,354,000 after purchasing an additional 4,145 shares during the period. Parkside Investments LLC bought a new position in UnitedHealth Group during the first quarter valued at $2,804,000. Finally, Clinton Group Inc. grew its holdings in UnitedHealth Group by 89.4% during the first quarter. Clinton Group Inc. now owns 56,017 shares of the healthcare conglomerate’s stock valued at $9,187,000 after purchasing an additional 26,440 shares during the period. 86.21% of the stock is owned by hedge funds and other institutional investors.
Several equities analysts have weighed in on the company. Jefferies Group LLC reissued a “buy” rating and set a $192.00 price objective on shares of UnitedHealth Group in a report on Friday, May 19th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 price objective for the company in a report on Wednesday, June 7th. Barclays PLC increased their target price on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 19th. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 14th. Finally, Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, June 9th. One analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $203.41.
UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.23% during mid-day trading on Friday, hitting $198.18. The company had a trading volume of 4,198,691 shares. The stock has a 50 day moving average price of $195.28 and a 200-day moving average price of $180.64. The stock has a market capitalization of $191.61 billion, a PE ratio of 23.81 and a beta of 0.63. UnitedHealth Group Incorporated has a 1-year low of $133.03 and a 1-year high of $200.76.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period last year, the firm earned $1.96 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio is presently 35.13%.
In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 25,600 shares of company stock worth $4,962,694. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.